AAP
KIDS icon

Arax Advisory Partners’s OrthoPediatrics KIDS Stock Holding History

Arax Advisory Partners’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-82
Closed -$1.52K – 4316
2025
Q3 		$1.52K Buy
+82
New +$1.69K ﹤0.01% 3163
2025
Q2 		– Sell
-73
Closed -$1.8K – 3133
2025
Q1 		$1.8K Hold
73
– – ﹤0.01% 2101
2024
Q4 		$1.69K Buy
73
+64
+711% +$1.6K ﹤0.01% 2046
2024
Q3 		$244 Hold
9
– – ﹤0.01% 2498
2024
Q2 		$259 Buy
+9
New +$276 ﹤0.01% 2422

Other funds holding KIDS

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Arax Advisory Partners's KIDS Position: Q4 2025 in Review

Arax Advisory Partners sold out of OrthoPediatrics (KIDS) in Q4 2025, closing a stake of 82 shares — an estimated $1.52K sold.

Arax Advisory Partners first reported a position in KIDS in Q2 2024 and held it in 5 quarters. The position peaked at $1.8K in Q1 2025. 120 funds tracked by Wall St. Rank hold KIDS as of Q4 2025.

  • Arax Advisory Partners reported no remaining OrthoPediatrics position as of Q4 2025 after selling out during the quarter.
  • Arax Advisory Partners sold 82 OrthoPediatrics shares in Q4 2025, an estimated $1.52K.
  • Arax Advisory Partners first reported a position in OrthoPediatrics in Q2 2024 and held it in 5 quarters.
  • Arax Advisory Partners's OrthoPediatrics position peaked at $1.8K in Q1 2025.
  • 120 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.